- REFINE YOUR SEARCH:
- 202All Results
Johns Hopkins ABX Guide
Johns Hopkins HIV Guide
Johns Hopkins Diabetes Guide
Johns Hopkins Psychiatry Guide
Medical News
Johns Hopkins Author Bios
Message Center - Hopkins Guides
Hepatitis B
202 results
1 - 100- Hepatitis B
- MICROBIOLOGY
- CLINICAL
- SITES OF INFECTION
- DIAGNOSTIC CHARACTERISTICS
- TREATMENT
- Treatment criteria (see definitions above):
- Treatment goals
- Monitoring therapy
- Peginterferon alfa 2a
- Entecavir (ETV)
- TDF and TAF
- Non-preferred therapies for HBV treatment
- Prevention
- Selected Drug Comments
- OTHER INFORMATION
- Basis for recommendation
- References
- Hepatitis B
- PATHOGENS
- CLINICAL
- DIAGNOSIS
- TREATMENT
- Goals of Therapy
- Criteria for Starting Therapy (among HIV+)
- Monitoring Therapy
- Criteria for Stopping Therapy
- HBV Therapies
- Treatment Categories
- Use of ART in HIV-HBV Co-infected
- Other Recommendations for Chronic HBV Co-infection
- Prevention
- Selected Drug Comments
- Pathogen Specific Therapy
- Basis for recommendation
- References
- Hepatitis B (HBV) vaccines
- Hepatitis, Non-A, B, C, D, or E
- Hepatitis D
- Entecavir
- Hep B-Hyperimmune globulin
- Vaccination Guidelines for Diabetes
- Adefovir
- Adefovir
- Interferon alfa
- Telbivudine
- Telbivudine
- Rotavirus vaccine
- Hepatitis A vaccine (HAV)
- Interferon alpha (ABX)
- Emtricitabine
- Emtricitabine
- Mark Sulkowski, M.D.
- HIV, Occupational Exposure
- Entecavir
- Haemophilus influenzae (Hib) vaccine
- Venous Sinus Thrombosis